Parkside Financial Bank & Trust’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-72
Closed -$17K 2065
2022
Q3
$17K Buy
72
+2
+3% +$540 0.01% 869
2022
Q2
$18K Sell
70
-42
-38% -$11.3K 0.01% 844
2022
Q1
$38K Buy
112
+55
+96% +$16.9K 0.01% 629
2021
Q4
$20K Buy
57
+8
+16% +$2.7K ﹤0.01% 818
2021
Q3
$16K Buy
49
+20
+69% +$6.78K ﹤0.01% 842
2021
Q2
$9K Sell
29
-3
-9% -$920 ﹤0.01% 1023
2021
Q1
$10K Buy
32
+3
+10% +$960 ﹤0.01% 947
2020
Q4
$9K Hold
29
﹤0.01% 924
2020
Q3
$8K Sell
29
-3
-9% -$864 ﹤0.01% 853
2020
Q2
$8K Buy
32
+6
+23% +$1.21K ﹤0.01% 855
2020
Q1
$4K Buy
26
+15
+136% +$2.49K ﹤0.01% 958
2019
Q4
$2K Buy
11
+3
+38% +$556 ﹤0.01% 1277
2019
Q3
$1K Sell
8
-2
-20% -$432 ﹤0.01% 1507
2019
Q2
$3K Sell
10
-32
-76% -$8.49K ﹤0.01% 1118
2019
Q1
$12K Sell
42
-18
-30% -$5.98K ﹤0.01% 747
2018
Q4
$20K Buy
60
+21
+54% +$7.29K 0.01% 573
2018
Q3
$18K Buy
+39
New +$15.4K 0.01% 638

Other funds holding ABMD

Parkside Financial Bank & Trust's ABMD Position: Q4 2022 in Review

Parkside Financial Bank & Trust sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 72 shares — an estimated $17K sold.

Parkside Financial Bank & Trust first reported a position in ABMD in Q3 2018 and held it in 17 quarters. The position peaked at $38K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Parkside Financial Bank & Trust reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 72 Abiomed Inc shares in Q4 2022, an estimated $17K.
  • Parkside Financial Bank & Trust first reported a position in Abiomed Inc in Q3 2018 and held it in 17 quarters.
  • Parkside Financial Bank & Trust's Abiomed Inc position peaked at $38K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2022, filed 14 Feb 2023.